» Articles » PMID: 30450128

Calcitonin Measurement in Fine-needle Aspirate Washout Fluid by Electrochemiluminescence Immunoassay for Thyroid Tumors

Overview
Journal Thyroid Res
Specialty Endocrinology
Date 2018 Nov 20
PMID 30450128
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: For the differential diagnosis of medullary thyroid carcinoma (MTC) on thyroid nodules, ultrasound-guided fine-needle aspiration cytology is a useful and safe procedure, but its diagnostic accuracy is not high enough. As an ancillary method to accurately diagnose MTC, the calcitonin in fine-needle aspirate washout fluid (FNA-Ct) is used. However, no data are available about cut-off values of FNA-Ct using the currently available electrochemiluminescence immunoassay (ECLIA).

Methods: We investigated 180 thyroid nodules in 141 patients. After smearing, the syringe and needle used for the FNA were rinsed with normal saline (0.5 mL). The calcitonin in the washout was measured by ECLIA.

Results: The FNA-Ct in the non-MTC nodules of MTC patients, non-MTC nodules of non-MTC patients, and MTC nodules were 10.6-2100 pg/mL (median 24.6 pg/mL), < 0.5-21.0 pg/mL (median < 0.5 pg/mL), and 94.9-4,070,000 pg/mL (median 177,000 pg/mL), respectively. A receiver operating characteristic analysis of the MTC nodules and the non-MTC nodules of the non-MTC patients indicated that the cut-off value was 21.0 pg/mL, leading to 100% sensitivity and 100% specificity.

Conclusions: This is the first study to determine the cut-off value of FNA-Ct with an ECLIA, and we propose that the optimal cut-off value is 21.0 pg/mL.

Citing Articles

Proposal for Clinical Management of Nodules Diagnosed as Atypia of Undetermined Significance via Thyroid Fine-Needle Aspiration Cytology in the Absence of Molecular Testing.

Suzuki A, Hirokawa M, Kawakami M, Kudo T, Miyauchi A, Akamizu T Cytopathology. 2025; 36(2):115-122.

PMID: 39794920 PMC: 11810542. DOI: 10.1111/cyt.13467.


The role of hormone dosages in the assessment of cervical lesions by FNA: A descriptive analysis of 762 cases.

Cunha-Volpato A, Sartorao Neto C, Ferraz da Silva L, Carneiro P Clinics (Sao Paulo). 2024; 80():100539.

PMID: 39612781 PMC: 11629572. DOI: 10.1016/j.clinsp.2024.100539.


Serum Biochemical Markers for Medullary Thyroid Carcinoma: An Update.

Liu S, Zhao H, Li X Cancer Manag Res. 2024; 16:299-310.

PMID: 38617188 PMC: 11011642. DOI: 10.2147/CMAR.S440477.


C-Cell Hyperplasia and Cystic Papillary Thyroid Carcinoma in a Patient with Type 1B Pseudohypoparathyroidism and Hypercalcitoninaemia: Case Report and Review of the Literature.

Ferrari D, Pandozzi C, Filice A, Nardi C, Cozzolino A, Melcarne R J Clin Med. 2023; 12(24).

PMID: 38137593 PMC: 10744305. DOI: 10.3390/jcm12247525.


Calcitonin levels in washout samples vs. cytology in the detection of malignant lymph node metastasis in recurrent medullary thyroid cancer.

Gokcay Canpolat A, Sahin M, Ceyhan K, Sak S, Demir O, Emral R Turk J Med Sci. 2021; 51(6):3061-3066.

PMID: 34519193 PMC: 10734873. DOI: 10.3906/sag-2105-280.


References
1.
Wells Jr S, Asa S, Dralle H, Elisei R, Evans D, Gagel R . Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015; 25(6):567-610. PMC: 4490627. DOI: 10.1089/thy.2014.0335. View

2.
Boi F, Maurelli I, Pinna G, Atzeni F, Piga M, Lai M . Calcitonin measurement in wash-out fluid from fine needle aspiration of neck masses in patients with primary and metastatic medullary thyroid carcinoma. J Clin Endocrinol Metab. 2007; 92(6):2115-8. DOI: 10.1210/jc.2007-0326. View

3.
Suzuki A, Hirokawa M, Takada N, Higuchi M, Ito A, Yamao N . Fine-needle aspiration cytology for medullary thyroid carcinoma: a single institutional experience in Japan. Endocr J. 2017; 64(11):1099-1104. DOI: 10.1507/endocrj.EJ17-0238. View

4.
Kudo T, Miyauchi A, Ito Y, Yabuta T, Inoue H, Higashiyama T . Serum calcitonin levels with calcium loading tests before and after total thyroidectomy in patients with thyroid diseases other than medullary thyroid carcinoma. Endocr J. 2011; 58(3):217-21. DOI: 10.1507/endocrj.k10e-359. View

5.
Redding A, Levine S, Fowler M . Normal preoperative calcitonin levels do not always exclude medullary thyroid carcinoma in patients with large palpable thyroid masses. Thyroid. 2000; 10(10):919-22. DOI: 10.1089/thy.2000.10.919. View